Medicine Online
Any medical inquiries? Search MOL for answers:
NEWS
Home > News > 2009 > February > 4 > Vectical Ointment Approved for Psoriasis
Medical References
Diseases & Conditions
Women's Health
Mental Health
Men's Health
Healthy Choice News
Site Map Links
Medical Tips
Attention, chocolate lovers: You may not be able to help yourselves. Swiss and British scientists have linked the widespread love of chocolate to a chemical "signature" that may be programmed into our metabolic systems.
Read more health news

Vectical Ointment Approved for Psoriasis

WEDNESDAY, Feb. 4 (HealthDay News) -- Galderma Laboratories'' Vectical (calcitriol) ointment has been approved by the U.S. Food and Drug Administration to treat mild-to-moderate plaque psoriasis in adults, the company said.

Approval was based on two eight-week studies involving more than 800 people. Improvement was first observed at week two, Galderma said in a news release.

The most frequently reported side effects included skin discomfort and high amounts of calcium in the urine.

Psoriasis is a chronic skin disorder characterized by thick, dry scaly patches. Up to 3 percent of the U.S. population has the disorder, accounting for millions of hours of lost productivity each year, the company said.

More information

To learn more about psoriasis, visit the U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases.



-- Scott Roberts

Last Updated: Feb. 04, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

HomeSitemap Contact UsAdvertisingPress RoomGive Us Your FeedbackRead Our Terms & Conditions and Our DisclaimerPrivacy Statement